Last reviewed · How we verify

NCT04442009

Superficial Cervical Plexus Block for Orthognathic Surgery

Withdrawn NA Last updated 4 May 2022
What this trial tests

NA trial testing Group SCPB in Maxillofacial Injuries. Withdrawn.

Timeline
22 June 2020
Primary endpoint
30 May 2022
30 June 2022

Quick facts

Lead sponsorMedipol University
PhaseNA
StatusWithdrawn
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Start date22 June 2020
Primary completion30 May 2022
Estimated completion30 June 2022
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Medipol University

Who can join

Adults 18 to 65, any sex, with Maxillofacial Injuries or Maxillofacial Trauma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

US-guided superficial cervical plexus block (SCPB) may be used for several head and neck surgeries. Local anesthetic is injected under the sternocleidomastoid muscle for SCPB. It has lower complication rate compared to the deep cervical plexus block. Postoperative pain management is important in patients underwent orthognathic surgery. Effective pain treatment provides early mobilization, and shorter hospital stay.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Maxillofacial Injuries

Currently open trials in the same condition.

Other Medipol University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04442009.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing